Related Experiment Video
Updated: Nov 28, 2025

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1
Ken-Ichi Yasuda1, Yoshimasa Nobeyama1, Takaoki Ishiji1
1Department of Dermatology The Jikei University School of Medicine Tokyo Japan.
Abstract:
Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c-NFs) and promote growth of pre-existing c-NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024